Meridigen Biotech Co., Ltd.
PrivateLast Round
Follow-on Offering
Jul 10, 2025
Total Funding Raised
$18.86M
Company Overview
Meridigen Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Follow-on Offering round in July 2025.
Meridigen Biotech Co., Ltd. is a biotechnology company that develops mesenchymal stem cell (MSC)-based technologies for manufacturing, characterization, storage, and drug discoveries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meridigen Biotech Co., Ltd. Comparables
Compare Meridigen Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SMSbiotech, Inc. | 83% | |
| Longeveron | 78% | |
| MEDIPOST Co., Ltd. | 77% |
For institutional investors. Book with your work email.
Meridigen Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jul 10, 2025 | ||||
| Follow-on Offering | Oct 24, 2024 | ||||
| Follow-on Offering | Apr 1, 2021 | ||||
| Follow-on Offering | Apr 1, 2016 | ||||
| Follow-on Offering | May 1, 2015 | ||||
VC Round | May 2, 2011 |
For institutional investors. Book with your work email.
Meridigen Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taipei City Government | Grant |
| UMC Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2025
$4M round completed.
- Oct 24, 2024
Completed a follow-on offering round.
For institutional investors. Book with your work email.
Meridigen Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Meridigen Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Meridigen Biotech Co., Ltd. a public or private company?
Meridigen Biotech Co., Ltd. is a private company.
What is the current stock price of Meridigen Biotech Co., Ltd.?
Meridigen Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Meridigen Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Meridigen Biotech Co., Ltd. worth (valuation)?
Valuation information for Meridigen Biotech Co., Ltd. is not publicly available.
Can I buy Meridigen Biotech Co., Ltd. stock?
Meridigen Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Meridigen Biotech Co., Ltd.'s last funding round?
Meridigen Biotech Co., Ltd.'s most recent funding round was Follow-on Offering on July 10, 2025.
Who are the main investors in Meridigen Biotech Co., Ltd.?
Key investors in Meridigen Biotech Co., Ltd. include UMC Capital.
Will Meridigen Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Meridigen Biotech Co., Ltd..
How can I track Meridigen Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Meridigen Biotech Co., Ltd.'s shares on secondary markets.